It is a pill presentation, which has two drugs that are tenofovir (viread) and emtricitabine (emtriva), which is approved by the FDA to treat infection caused by HIV AIDS, and what is called prophylaxis, is In other words, it reduces the risk of contagion of the disease or of transmitting it.
It is used in adult patients and in underage children, but in the case of children they should not weigh less than 20 kilos, it is used daily and constantly, and it is a complement to the other drugs used for HIV, since which helps other retrovirals to maintain high levels and HIV-positive patients who are exposed to the virus to reduce the levels of contagion, and to lead a healthy and safe life together with the use of condoms.
As with any medication, the benefits and weaknesses of its daily use must be taken into account, although it is true that it improves the quality of life of both infected and non-infected, it is reasonable to have the following considerations, for example if you suffer from medical hypersensitivity or if you are allergic to any component of truvada, if you suffer from the pancreas, liver or kidneys, hepatitis B (VIB), or if you suffer from any malformation or weakness of the bones since it tends to decrease bone density, or if you are suffering from other medical deficiencies in the body, clinically speaking.
In the case of women who want to get pregnant or if they are already pregnant, or are breastfeeding, its use is not recommended since the short, medium and long-term effects have not yet been purchased in the baby, and they may have a complicated life in the future, in women with HIV infection it is recommended not to breastfeed and especially if you are taking truvada. In case the patient is taking more than one drug at the same time, whether it is clinical or natural, truvada may decrease its effect of the drug and the side effects may vary, such as increasing those already suffered, making them more persistent.
